Literature DB >> 21070867

PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

David Alvarez-Guardia1, Xavier Palomer, Teresa Coll, Lucía Serrano, Ricardo Rodríguez-Calvo, Mercy M Davidson, Manuel Merlos, Ilhem El Kochairi, Liliane Michalik, Walter Wahli, Manuel Vázquez-Carrera.   

Abstract

Owing to its high fat content, the classical Western diet has a range of adverse effects on the heart, including enhanced inflammation, hypertrophy, and contractile dysfunction. Proinflammatory factors secreted by cardiac cells, which are under the transcriptional control of nuclear factor-κB (NF-κB), may contribute to heart failure and dilated cardiomyopathy. The underlying mechanisms are complex, since they are linked to systemic metabolic abnormalities and changes in cardiomyocyte phenotype. Peroxisome proliferator-activated receptors (PPARs) are transcription factors that regulate metabolism and are capable of limiting myocardial inflammation and hypertrophy via inhibition of NF-κB. Since PPARβ/δ is the most prevalent PPAR isoform in the heart, we analyzed the effects of the PPARβ/δ agonist GW501516 on inflammatory parameters. A high-fat diet induced the expression of tumor necrosis factor-α, monocyte chemoattractant protein-1, and interleukin-6, and enhanced the activity of NF-κB in the heart of mice. GW501516 abrogated this enhanced proinflammatory profile. Similar results were obtained when human cardiac AC16 cells exposed to palmitate were coincubated with GW501516. PPARβ/δ activation by GW501516 enhanced the physical interaction between PPARβ/δ and p65, which suggests that this mechanism may also interfere NF-κB transactivation capacity in the heart. GW501516-induced PPARβ/δ activation can attenuate the inflammatory response induced in human cardiac AC16 cells exposed to the saturated fatty acid palmitate and in mice fed a high-fat diet. This is relevant, especially taking into account that PPARβ/δ has been postulated as a potential target in the treatment of obesity and the insulin resistance state. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070867     DOI: 10.1016/j.bbalip.2010.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

2.  Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.

Authors:  Ronald B Myers; Jun Yoshioka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

Review 3.  Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Authors:  Jeffrey M Peters; Jennifer E Foreman; Frank J Gonzalez
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).

Authors:  Jeffrey M Peters; Jose L Morales; Frank J Gonzalez
Journal:  Drug Discov Today Dis Mech       Date:  2011-11-29

5.  High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagy.

Authors:  Hsiu-Ching Hsu; Ching-Yi Chen; Bai-Chin Lee; Ming-Fong Chen
Journal:  Eur J Nutr       Date:  2015-09-10       Impact factor: 5.614

Review 6.  Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance.

Authors:  Evangelos Oikonomou; Konstantinos Mourouzis; Petros Fountoulakis; Georgios Angelos Papamikroulis; Gerasimos Siasos; Alexis Antonopoulos; Georgia Vogiatzi; Sotiris Tsalamadris; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

7.  Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity.

Authors:  Heidi E Kocalis; Maxine K Turney; Richard L Printz; Gloria N Laryea; Louis J Muglia; Sean S Davies; Gregg D Stanwood; Owen P McGuinness; Kevin D Niswender
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

Review 8.  Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.

Authors:  Francisco A Monsalve; Radha D Pyarasani; Fernando Delgado-Lopez; Rodrigo Moore-Carrasco
Journal:  Mediators Inflamm       Date:  2013-05-27       Impact factor: 4.711

9.  Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions.

Authors:  Sibel Ertek; Arrigo Cicero
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

10.  Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors.

Authors:  Stéphane Mandard; David Patsouris
Journal:  PPAR Res       Date:  2013-03-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.